Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Tenet Healthcare Corporation THC

Financial statements are limited to most recent four years or quarters for non-powerpack users

Ten years worth of data (where available), most important trends and XLS exports are available for our Powerpack users.
Dec '25
Dec '24
Dec '23
Dec '22
Dec '21
Dec '20
Dec '19
Dec '18
Dec '17
Dec '16
P/E ratio
12.73
3.88
12.63
12.76
‡‡‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡
P/S ratio
0.84
0.59
0.38
0.27
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
P/FCF ratio
7.08
10.96
4.76
16.32
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡
P/Operating CF
24.51
(36.96)
9.38
12.44
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
P/B ratio
2.98
2.10
2.48
2.13
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Price to Tangible BV
0.00
0.00
0.00
0.00
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
EV/Sales
1.32
1.08
1.05
1.01
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EV/EBITDA
6.42
3.29
6.30
6.07
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EV/Operating CF
7.97
10.94
9.06
17.97
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EV/FCF
11.15
20.06
13.25
60.62
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Quick Ratio
1.22
1.29
0.87
0.85
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Current Ratio
1.76
1.78
1.51
1.34
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Net Debt/EBITDA
2.34
1.49
4.04
4.43
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Debt/Assets
44.38%
45.52%
52.99%
55.53%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Debt/Equity
2.19
2.26
4.81
6.13
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Asset Turnover
0.73
0.72
0.74
0.70
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Operating CF/Net income
2.52
0.64
3.89
2.64
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Capex/Depreciation
(1.14)
(1.10)
(0.83)
(0.87)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Depreciation/Fixed assets
0.14
0.14
0.14
0.14
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡
‡‡‡‡‡
Interest Coverage
0.00
0.00
0.00
0.00
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
ROE
23.77%
71.61%
21.92%
18.21%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
ROA
4.80%
11.18%
2.20%
1.50%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
ROIC
13.45%
23.30%
9.29%
8.74%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Cash ROIC
(12.57%)
(18.18%)
(19.96%)
(29.24%)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Return on Tangible Assets
14.50%
33.97%
7.07%
5.16%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Accounts Receivable Turnover
8.36
7.59
7.02
6.71
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Accounts Payable Turnover
9.41
9.21
8.75
8.64
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Inventory Turnover
35.98
32.89
31.22
30.71
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Average Days of Receivables
43.93
44.77
51.72
56.02
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Average Days of Payables
39.76
37.94
40.35
45.30
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Days of Inventory on Hand
10.17
10.15
11.78
12.20
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Research and Development Expense of Revenue
0.00%
0.00%
0.00%
0.00%
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
‡‡‡
Selling, General and Administrative Expense of Revenue
0.00%
0.00%
0.00%
0.29%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡
‡‡‡
Intangible Assets out of Total Assets
0.42
0.42
0.41
0.43
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Share Based Compensation of Revenue
0.49%
0.32%
0.32%
0.29%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Graham Net Nets
(0.88)
(1.26)
(2.33)
(3.57)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Graham Number
153.11
209.66
64.45
44.57
‡‡‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡‡‡
‡‡‡
‡‡‡
Earnings Yield
7.86%
25.77%
7.92%
7.84%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Free Cash Flow Yield
14.12%
9.12%
21.00%
6.13%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Revenue per Share
236.38
213.36
202.32
179.32
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Operating CF per Share
39.27
21.12
23.36
10.13
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Capex per Share
(11.20)
(9.61)
(7.39)
(7.13)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Free Cash Flow per Share
28.06
11.52
15.97
3.00
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Cash per Share
31.98
31.15
12.08
8.02
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Shareholders Equity per Share
66.74
60.06
30.67
23.00
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Interest Debt per Share
0.00
0.00
0.00
0.00
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Book value per Share
66.74
60.06
30.67
23.00
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Free Cash Flow
2,530.00
1,116.00
1,623.00
321.00
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Working Capital
3,386.00
3,372.00
2,407.00
1,505.00
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Capital Expenditures
(1,010.00)
(931.00)
(751.00)
(762.00)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Net Current Asset Value
(15,811.00)
(15,434.00)
(18,028.00)
(18,716.00)
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Average Receivables
2,550.50
2,725.00
2,928.50
2,856.50
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Average Payables
1,327.00
1,351.00
1,456.00
1,402.00
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Average Inventory
347.00
378.50
408.00
394.50
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Average Assets
29,306.50
28,624.00
27,734.00
27,367.50
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Average Common Equity
5,918.50
4,468.50
2,788.00
2,256.50
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
EV/EBIT
8.04
3.76
8.57
8.34
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Capex to Sales
0.05
0.05
0.04
0.04
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Net Profit Margin
6.60%
15.48%
2.97%
2.14%
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
Price to Operating Income
5.11
2.05
3.08
2.24
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡
‡‡‡‡‡